JP2014530607A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014530607A5 JP2014530607A5 JP2014535033A JP2014535033A JP2014530607A5 JP 2014530607 A5 JP2014530607 A5 JP 2014530607A5 JP 2014535033 A JP2014535033 A JP 2014535033A JP 2014535033 A JP2014535033 A JP 2014535033A JP 2014530607 A5 JP2014530607 A5 JP 2014530607A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- transcription factor
- artificial transcription
- receptor
- factor according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11184706 | 2011-10-11 | ||
| EP11184706.7 | 2011-10-11 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014530607A JP2014530607A (ja) | 2014-11-20 |
| JP2014530607A5 true JP2014530607A5 (https=) | 2015-11-26 |
Family
ID=47045011
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014535033A Pending JP2014530607A (ja) | 2011-10-11 | 2012-10-10 | 人工転写因子の送達による受容体発現の調節 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20140296129A1 (https=) |
| EP (1) | EP2766484A2 (https=) |
| JP (1) | JP2014530607A (https=) |
| KR (1) | KR20140079780A (https=) |
| CN (1) | CN103998609A (https=) |
| AU (1) | AU2012323032A1 (https=) |
| BR (1) | BR112014008456A2 (https=) |
| CA (1) | CA2851560A1 (https=) |
| CL (1) | CL2014000897A1 (https=) |
| CO (1) | CO6930308A2 (https=) |
| EA (1) | EA201490531A1 (https=) |
| HK (1) | HK1197083A1 (https=) |
| IL (1) | IL231865A0 (https=) |
| IN (1) | IN2014CN02586A (https=) |
| MA (1) | MA36970A1 (https=) |
| MX (1) | MX2014004331A (https=) |
| PH (1) | PH12014500786A1 (https=) |
| SG (1) | SG11201400701WA (https=) |
| TN (1) | TN2014000117A1 (https=) |
| WO (1) | WO2013053719A2 (https=) |
| ZA (1) | ZA201401960B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2015311704B2 (en) | 2014-09-07 | 2021-12-09 | Selecta Biosciences, Inc. | Methods and compositions for attenuating gene editing anti-viral transfer vector immune responses |
| AU2018347583A1 (en) | 2017-10-13 | 2020-05-21 | Selecta Biosciences, Inc. | Methods and compositions for attenuating anti-viral transfer vector IgM responses |
| WO2019195285A1 (en) * | 2018-04-02 | 2019-10-10 | University Of Miami | Ifn-beta reporter system for immortalized primary cells |
| CA3141863A1 (en) | 2019-05-28 | 2020-12-03 | Selecta Biosciences, Inc. | Methods and compositions for attenuated anti-viral transfer vector immune response |
| AU2020405068A1 (en) | 2019-12-18 | 2022-07-07 | Stinginn Llc | Substituted 1,2, 4-triazoles and methods of use |
| CN111304314B (zh) * | 2020-02-25 | 2020-11-20 | 四川省人民医院 | Znf124基因在视网膜色素变性疾病早期筛查或辅助诊断中的应用 |
| US20220049310A1 (en) * | 2020-02-25 | 2022-02-17 | Sichuan Provincial People's Hospital | Use of ZNF124 Gene in Early Screening or Auxiliary Diagnosis of Retinitis Pigmentosa Disease |
| US11897888B1 (en) | 2020-04-30 | 2024-02-13 | Stinginn Llc | Small molecular inhibitors of sting signaling compositions and methods of use |
| WO2023064367A1 (en) | 2021-10-12 | 2023-04-20 | Selecta Biosciences, Inc. | Methods and compositions for attenuating anti-viral transfer vector igm responses |
| WO2023172624A1 (en) | 2022-03-09 | 2023-09-14 | Selecta Biosciences, Inc. | Immunosuppressants in combination with anti-igm agents and related dosing |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE524545T1 (de) * | 1994-08-20 | 2011-09-15 | Gendaq Ltd | Verbesserungen bei oder im zusammenhang mit bindeproteinen zur erkennung von dna |
| US6534261B1 (en) * | 1999-01-12 | 2003-03-18 | Sangamo Biosciences, Inc. | Regulation of endogenous gene expression in cells using zinc finger proteins |
| AU2964101A (en) * | 2000-01-21 | 2001-07-31 | Scripps Research Institute, The | Methods and compositions to modulate expression in plants |
| US20020061512A1 (en) * | 2000-02-18 | 2002-05-23 | Kim Jin-Soo | Zinc finger domains and methods of identifying same |
| NZ527476A (en) * | 2001-02-21 | 2006-06-30 | Novartis Ag | Zinc finger binding domains for nucleotide sequence ANN |
| US20030077279A1 (en) * | 2001-10-24 | 2003-04-24 | Cedars-Sinai Medical Center | Methods for treating vascular disease by inhibiting toll-like receptor-4 |
| US20060094676A1 (en) * | 2004-10-29 | 2006-05-04 | Ronit Lahav | Compositions and methods for treating cancer using compositions comprising an inhibitor of endothelin receptor activity |
| EP1929032A4 (en) * | 2005-09-30 | 2009-11-04 | Oklahoma Med Res Found | REGULATION OF GOOD LIKE RECEPTORS ON STEM CELLS |
| WO2008140538A1 (en) * | 2006-10-04 | 2008-11-20 | Verenium Corporation | Dna display screen for expression product with desired binding properties |
| GB0620705D0 (en) * | 2006-10-18 | 2006-11-29 | Opsona Therapeutics | Compounds for the modulation of toll-like receptor activity and assay methods for the identification of said compounds |
| CN101333251A (zh) * | 2008-01-30 | 2008-12-31 | 中国人民解放军第三军医大学 | 能启动a20基因表达的人工锌指蛋白转录因子及用途 |
| US20110318830A1 (en) * | 2008-11-12 | 2011-12-29 | The Regents Of The University Of California | Compositions and methods for re-programming and re-differentiating cells |
| EP2411518A2 (en) * | 2009-03-27 | 2012-02-01 | Merck Sharp&Dohme Corp. | Rna interference mediated inhibition of the high affinity ige receptor alpha chain (fcerla) gene expression using short interfering nucleic acid (sina) |
| EP2509594A1 (en) * | 2009-12-09 | 2012-10-17 | INSERM - Institut National de la Santé et de la Recherche Médicale | Endothelin inhibitors for the treatment of rapidly progressive glomerulonephritis |
-
2012
- 2012-10-10 IN IN2586CHN2014 patent/IN2014CN02586A/en unknown
- 2012-10-10 CA CA2851560A patent/CA2851560A1/en not_active Abandoned
- 2012-10-10 US US14/349,443 patent/US20140296129A1/en not_active Abandoned
- 2012-10-10 AU AU2012323032A patent/AU2012323032A1/en not_active Abandoned
- 2012-10-10 CN CN201280049781.2A patent/CN103998609A/zh active Pending
- 2012-10-10 WO PCT/EP2012/069981 patent/WO2013053719A2/en not_active Ceased
- 2012-10-10 PH PH1/2014/500786A patent/PH12014500786A1/en unknown
- 2012-10-10 BR BR112014008456A patent/BR112014008456A2/pt not_active IP Right Cessation
- 2012-10-10 EA EA201490531A patent/EA201490531A1/ru unknown
- 2012-10-10 MA MA36970A patent/MA36970A1/fr unknown
- 2012-10-10 EP EP12774996.8A patent/EP2766484A2/en not_active Withdrawn
- 2012-10-10 JP JP2014535033A patent/JP2014530607A/ja active Pending
- 2012-10-10 SG SG11201400701WA patent/SG11201400701WA/en unknown
- 2012-10-10 KR KR1020147009933A patent/KR20140079780A/ko not_active Withdrawn
- 2012-10-10 MX MX2014004331A patent/MX2014004331A/es unknown
- 2012-10-10 HK HK14110571.0A patent/HK1197083A1/xx unknown
-
2014
- 2014-03-18 ZA ZA2014/01960A patent/ZA201401960B/en unknown
- 2014-03-19 TN TNP2014000117A patent/TN2014000117A1/en unknown
- 2014-04-01 IL IL231865A patent/IL231865A0/en unknown
- 2014-04-09 CO CO14077166A patent/CO6930308A2/es unknown
- 2014-04-10 CL CL2014000897A patent/CL2014000897A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014530607A5 (https=) | ||
| Wagner et al. | The senescence markers p16INK4A, p14ARF/p19ARF, and p21 in organ development and homeostasis | |
| Huilgol et al. | Transcription factors that govern development and disease: an achilles heel in cancer | |
| O'Brien et al. | Differential regulation of mouse and human nephron progenitors by the Six family of transcriptional regulators | |
| Small et al. | Transcriptional regulation of a pair-rule stripe in Drosophila. | |
| Meadows et al. | Regulation of endothelial cell development by ETS transcription factors | |
| Agoston et al. | Genetic and physical interaction of Meis2, Pax3 and Pax7 during dorsal midbrain development | |
| Gommans et al. | Engineering zinc finger protein transcription factors: the therapeutic relevance of switching endogenous gene expression on or off at command | |
| Khurana et al. | The role of actin bundling proteins in the assembly of filopodia in epithelial cells | |
| Orange et al. | Cell penetrating peptide inhibitors of nuclear factor-kappa B | |
| Murano et al. | Hes1 promotes the IL-22-mediated antimicrobial response by enhancing STAT3-dependent transcription in human intestinal epithelial cells | |
| JP2015533817A5 (https=) | ||
| RU2016106583A (ru) | Пептиды, способные реактивировать мутанты р53 | |
| JP2016527891A5 (https=) | ||
| Waby et al. | Post-translational control of sp-family transcription factors | |
| Perry et al. | Direct interaction between myocyte enhancer factor 2 (MEF2) and protein phosphatase 1α represses MEF2-dependent gene expression | |
| Sardet et al. | E2Fs and the retinoblastoma protein family | |
| Hyndman et al. | E2A proteins enhance the histone acetyltransferase activity of the transcriptional co-activators CBP and p300 | |
| García-Palmero et al. | Calmodulin regulates the translocation of Grb7 into the nucleus | |
| Rho et al. | A novel cervical cancer suppressor 3 (CCS-3) interacts with the BTB domain of PLZF and inhibits the cell growth by inducing apoptosis | |
| Hyndman et al. | Mapping acetylation sites in E2A identifies a conserved lysine residue in activation domain 1 that promotes CBP/p300 recruitment and transcriptional activation | |
| Kozasa | Regulation of G protein-mediated signal transduction by RGS proteins | |
| Sánchez et al. | Drosophila Sal and Salr are transcriptional repressors | |
| Neto et al. | Activation of human T lymphocytes via integrin signaling induced by RGD-disintegrins | |
| Kristie | Early events pre-initiation of alphaherpes viral gene expression |